Recent Updates
Recently added Catalysts

Medline Inc.

MDLN
MedTech · Commercial
FDA catalysts, PDUFA dates & pipeline intelligence
$35.74
▲ +0.29 · +0.82%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full MDLN financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $31.4952W HIGH $50.88
Volume
10.19 M
Value Traded
328.26 M
Short % Float
8.1%
+0.37%Week
+4.96%1 Month
-12.91%3 Month
-21.62%6 Month
-2.99%5 Year
-2.99%All Time

Cash Data

Unlock MDLN cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
46.99 B
EPS (TTM)
0.92
P/E Ratio
38.71
Ent. Value
56.89 B
Total Shares
1.31 B
Float Shares
509.79 M
Insiders
41.89%
Institutions
74.10%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every MDLN catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

MDLN Catalyst Timeline

Dated clinical, regulatory and corporate events for Medline Inc.

Catalyst Timeline

Dated clinical, regulatory & corporate events for Medline Inc.

23Total events
2Upcoming
3Tier-1 (high impact)
2025 to 2027Coverage

Upcoming catalysts 2

T2Quarterly Update
Subscribe to view catalyst details
T3Manufacturing Milestone
Subscribe to view catalyst details

Event history 17

●Quarterly UpdateCorporate
Medline reports first six months 2026 results
●Runway Guidance UpdateCorporate
Medline updates FY2026 Organic Sales growth guidance to 9.0%-10.0% and Adjusted EBITDA guidance to $3.3B-$3.4B
▲Product LaunchPost-Market
Medline Canada begins warehouse and supply chain logistics for Mohawk Medbuy hospitals
▼Supply DisruptionCMC / Inspection
Fire at Tracy, California distribution center
▲Partnership / LicenseCorporate
Access Vascular and Medline enter multi-year agreement to launch cobranded next-generation vascular access catheters
vascular accesssource ↗
◆Oral PresentationPresentation
Goldman Sachs 47th Annual Global Healthcare Conference presentation
◆Oral PresentationPresentation
William Blair 46th Annual Growth Stock Conference presentation
▲Partnership / LicenseCorporate
Medline Canada signs first Prime Vendor agreement with Mohawk Medbuy
▼Equity OfferingCorporate
Upsized secondary offering of 72,554,594 shares of Class A common stock closed at $37.00 per share
▼Equity OfferingCorporate
Pricing of upsized secondary offering of Class A common stock at $37.00 per share
Unlock the full MDLN catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How MDLN actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
2018-11-20Readyprep Chg (chlorhexidine gluconate) PDUFA Date ApprovedPDUFA
Unlock all MDLN historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

D38 / 100
Pipeline Score
$554M
Pipeline Value
Not rated
Valuation Signal
2
Drugs Scored
-
rNPV / MCap
Top 45%
Mid Cap
(rank 297 of 658)
Percentile Rank
Medline Inc. faces pipeline headwinds (38/100), with $652M risk-adjusted pipeline value, led by 2% CHG in Skin Coverage (Phase 2).
Showing 1 of 2 assets
DrugIndicationPhasePTRSrNPVStatusEnrollVelocityDesignEst. CompletionML SignalLast Change
2% CHG Small moleculeCompletedNCT03326726Skin CoveragePhase 2 COMPLETED 30Nov 18, 2016
Unlock the MDLN pipeline intelligence model
Every scored asset with PTRS, rNPV, enrollment velocity and trial design quality.
Institutional-grade data · Cancel anytime

Clinical Trial Results

Readouts, endpoints and source filings for every MDLN program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every MDLN trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock MDLN insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
GIC Private Ltd10% OwnerSell -2,088,987 16,453,806 held$35.05 10/06/2026
Unlock the full MDLN insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
RTW INVESTMENTS, LP 0 % 2.76 M 70.00 K
Unlock every fund holding MDLN
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in MDLN
Shares held by hedge funds each quarter, and who bought or sold.

MDLN Institutional Ownership Trends

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2027-01-15
Unlock MDLN option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live MDLN option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock MDLN options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How MDLN ranks across every disease it competes in

Competitive Position is a premium feature
See how MDLN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

MDLN News

MDLN
Oct 6, 2026
MDLNGeneral
▲ +0.8%today

Medline to report third quarter 2026 results on November 4, 2026

Medline Inc. announced its plans to report third quarter 2026 financial results on November 4, 2026. A press release will precede the market opening, followed by a conference call at 9:30 AM ET. Investors can access the live webcast and subsequent replay through Medline's Investor Relations website.

Read more →
MDLN
Oct 1, 2026
MDLNGeneral

Medline lanza la campaña «10 minutos que importan» para destacar el valor del tiempo en el quirófano

Medline EMEA has launched the '10 Minutes That Matter' campaign to emphasize the importance of time in the operating room. The initiative showcases how practical solutions can help healthcare professionals optimize their time, ultimately improving patient care. A study revealed that using customized surgical trays significantly reduced preparation time, allowing staff to focus more on patient needs.

Read more →
MDLN
Oct 1, 2026
MDLNGeneral

Medline startet die Kampagne „10 Minuten, die den Unterschied machen ", um den Wert der Zeit im Operationssaal hervorzuheben

Medline has launched the '10 Minutes That Make a Difference' campaign to emphasize the value of time in the operating room. The initiative showcases how practical solutions can aid medical professionals, particularly in reducing preparation times for surgeries. A study indicated that using custom surgical trays can save over 10 minutes, allowing teams to focus more on patient care. Medline aims to enhance healthcare efficiency by simplifying processes behind the scenes.

Read more →
MDLN
Oct 1, 2026
MDLNGeneral

Medline lance la campagne « 10 Minutes That Matter » pour mettre en avant l'importance du temps au bloc opératoire

Medline EMEA has launched the '10 Minutes That Matter' campaign to highlight the importance of time in the operating room. The initiative aims to improve efficiency and reduce stress for healthcare professionals by promoting custom sterile trays that save preparation time. This campaign underscores the human value of time in patient care.

Read more →
MDLN
Oct 1, 2026
MDLNGeneral

Medline launches "10 Minutes That Matter" campaign to spotlight the value of time in the operating theatre

Medline EMEA has launched the '10 Minutes That Matter' campaign to emphasize the importance of time in the operating theatre. The initiative aims to showcase how practical solutions can enhance efficiency and reduce stress for healthcare professionals. By focusing on the value of time, Medline seeks to improve patient care and streamline surgical processes.

Read more →
MDLN
Sep 14, 2026
MDLNGeneral

Medline Canada announces plan to expand warehouse and distribution capacity in British Columbia at the Parkwood Industrial Estates

Medline Canada has announced plans to develop a new warehouse and distribution center in Delta, British Columbia, nearly doubling its existing capacity. The facility, set to be completed in 2028, will serve as a hub for healthcare and dental businesses in Western Canada. This investment aims to enhance distribution efficiency and support future growth.

Read more →
MDLN
Sep 3, 2026
MDLNConferences/Events

Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference

Medline Inc. announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference, scheduled for September 15, 2026. CEO Jim Boyle and CFO Mike Drazin will present at the event in New York. A webcast of the presentation will be available, allowing broader access for investors and stakeholders.

Read more →
MDLN
Aug 5, 2026
MDLNGeneral
▼ -12.8%on this news

Medline Reports Second Quarter and First Six Months 2026 Results

Medline reported its Q2 and first six months results for 2026, showing a net sales increase of 11.6% to $7.7 billion, despite a significant net income drop of 58.3% due to operational challenges. The company updated its full-year guidance for Organic Sales growth to 9.0%-10.0%, reflecting strong demand and new customer signings. Adjusted EBITDA also saw an increase, highlighting operational resilience amidst external pressures.

Read more →
MDLN
Jul 28, 2026
MDLNGeneral

Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

Dentsply Sirona has announced an expansion of its partnership with Medline Sinclair, allowing the latter to distribute Dentsply's technology portfolio across Canada starting September 1, 2026. This move aims to enhance access to digital dentistry solutions through Medline Sinclair's extensive sales and service network. The partnership reflects Dentsply Sirona's commitment to strengthening its commercial reach in North America.

Read more →
MDLN
Jul 20, 2026
MDLNGeneral

Medline strengthens California distribution network with new 1 million-square-foot facility in Perris

Medline has announced the opening of a new 1 million-square-foot distribution center in Perris, California, aimed at strengthening its supply chain resilience. This facility is part of a broader investment in Medline's California distribution network, which is expected to reach nearly 5 million square feet by mid-2027. The expansion follows a recent fire at another site, highlighting the company's commitment to supporting healthcare providers in the state.

Read more →
MDLN
Jul 14, 2026
MDLNGeneral

Medline releases 2025 Sustainability Report highlighting continued progress across operations, products and communities

Medline has released its 2025 Sustainability Report, showcasing advancements in environmental, social, and governance initiatives. Key highlights include the successful Tote-Cart Initiative, which reduced diesel fuel usage, and the certification of 46 facilities by WRAP for ethical sourcing. The company aims to further integrate sustainability into its operations in 2026, emphasizing collaboration with customers and suppliers.

Read more →
MDLN
Jul 8, 2026
MDLNGeneral

Medline announces Prime Vendor agreement with Allina Health

Medline has entered into a Prime Vendor agreement with Allina Health, enhancing access to its medical-surgical products and supply chain solutions. This partnership aims to improve supply reliability and streamline the ordering process for Allina Health's network of hospitals and clinics. Both organizations emphasize the importance of supporting quality patient care through this collaboration.

Read more →
MDLN
Jul 6, 2026
MDLNGeneral

Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California

Medline has secured two new distribution centers in Northern California, totaling over 1.6 million square feet, to replace a facility lost to fire. This expansion represents a 45% increase in their customer-facing footprint in the region. The new centers will enhance service capabilities for healthcare providers and are expected to incorporate advanced technologies.

Read more →
MDLN
Jul 1, 2026
MDLNGeneral
▲ +5.8%on this newsshared move

Medline to report second quarter 2026 results on August 5, 2026

Medline Inc. has announced its plan to report second quarter 2026 financial results on August 5, 2026. A press release and supplemental materials will precede the market opening. The company will also host a conference call and webcast to discuss the results, with details available on its Investor Relations website.

Read more →
MDLN
Jun 23, 2026
MDLNGeneral

Access Vascular and Medline Enter Multi-Year Agreement to Launch Cobranded Next-Generation Vascular Access Catheters

Access Vascular and Medline have announced a multi-year agreement to launch cobranded next-generation vascular access catheters. This partnership aims to enhance the quality and efficiency of vascular access solutions. The details regarding the specific features and benefits of the new catheters have not been disclosed.

Read more →
MDLN
Jun 8, 2026
MDLNGeneral

Medline amplía su presencia manufacturera en Eslovaquia para respaldar el crecimiento a largo plazo en Europa

Medline International B.V. is expanding its manufacturing presence in Partizánske, Slovakia, to enhance production capacity and support long-term growth in Europe. The new facility, set to begin operations in 2027, will feature improved operational flows and a cleanroom. This expansion reflects Medline's commitment to excellence and sustainability in healthcare solutions.

Read more →
MDLN
Jun 8, 2026
MDLNGeneral

Medline Expands Manufacturing Footprint in Slovakia to Support Long-Term Growth in Europe

Medline International B.V. is expanding its manufacturing facility in Partizánske, Slovakia, to enhance production capacity and support growth in Europe. The new facility, set to begin operations in 2027, will feature advanced clean room technology and energy-efficient systems. This expansion underscores Medline's commitment to operational excellence and sustainability while creating new job opportunities.

Read more →
MDLN
Jun 8, 2026
MDLNGeneral

Medline erweitert seine Produktionskapazitäten in der Slowakei, um das langfristige Wachstum in Europa zu unterstützen

Medline International B.V. is expanding its production facility in Partizánske, Slovakia, to enhance its manufacturing capacity and support long-term growth in Europe. The new facility is set to begin operations in 2027 and will include advanced cleanroom technology. This expansion aims to improve efficiency and reliability for customers while creating new jobs in the region.

Read more →
MDLN
Jun 1, 2026
MDLNGeneral

Medline’s Prime Vendor model expands outside the United States

Medline has signed its first Prime Vendor agreement in Canada with Mohawk Medbuy, marking a significant expansion of its services outside the U.S. This agreement aims to improve supply chain logistics for hospitals in Southwestern Ontario by implementing a stockless distribution model. The initiative is expected to enhance service reliability and efficiency in healthcare delivery.

Read more →
MDLN
May 29, 2026
MDLNGeneral

Medline's Prime Vendor model expands outside the United States

Medline has signed its first Prime Vendor agreement in Canada with Mohawk Medbuy, marking a significant expansion outside the U.S. This partnership aims to enhance supply chain logistics for hospitals in Southwestern Ontario by implementing a stockless distribution model. The agreement is expected to improve service reliability and efficiency in delivering medical supplies.

Read more →

About Medline Inc.

Northfield, IL 45,000 employees medline.com
Headquarters3 LAKES DRIVE, NORTHFIELD, IL, 60093
BIOPHARMAWATCH ELITE PLUS
Trade the next MDLN catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime